首页> Journal of the National Comprehensive Cancer Network : JNCCN> Disease Outcomes in Immune-Mediated Colitis: A Study Describing Initial Endoscopic and Histologic Presentations and Treatment Options.

Disease Outcomes in Immune-Mediated Colitis: A Study Describing Initial Endoscopic and Histologic Presentations and Treatment Options.

导出 LinkOut

翻译打印收藏纠错

第一作者： Malek,Shatila

第一单位： 1Department of Gastroenterology, Hepatology, and Nutrition, The University of Texas MD Anderson Cancer Center, Houston TX.

作者： Malek,Shatila ^[1] ; Carolina Colli,Cruz ^[1] ; Kei,Takigawa ^[2] ; Andres Caleb,Urias Rivera ^[2] ; Kian,Abdul-Baki ^[3] ; Tanvi,Gupta ^[4] ; Elliot,Baerman ^[2] ; Linfeng,Lu ^[2] ; Irene Jeong-Ah,Lee ^[2] ; Raakhi,Menon ^[3] ; Andrew,Sullivan ^[4] ; Varun,Vemulapalli ^[4] ; Cristina,Natha ^[4] ; Hamza,Salim ^[5] ; Ayesha,Khan ^[3] ; Krishnavathana,Varatharajalu ^[1] ; Douglas,Johnson ^[6] ; Karen,Kim ^[7] ; Stephane,Champiat ^[8] ; Anusha Shirwaiker,Thomas ^[1] ; Yinghong,Wang ^[1]

作者单位： 1Department of Gastroenterology, Hepatology, and Nutrition, The University of Texas MD Anderson Cancer Center, Houston TX. ^[1] 2Department of Internal Medicine, Baylor College of Medicine, Houston, TX. ^[2] 3Department of Internal Medicine, The University of Texas Medical Branch, Galveston, TX. ^[3] 4Department of Internal Medicine, The University of Texas Health Sciences Center, Houston, TX. ^[4] 5The Memorial Hermann Texas Medical Center, Houston, TX. ^[5] 6Division of Hematology and Oncology, Vanderbilt University, Nashville, TN. ^[6] 7Department of Gastroenterology and Hepatology, Stanford Medicine, Stanford, CA. ^[7] 8Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX. ^[8]